Trade Summary

2 days ago, Kihara James, serving as PRINCIPAL ACCOUNTING OFFICER at Acadia Pharmaceuticals Inc (ACAD), sold 1,332 shares at $21.79 per share, for a total transaction value of $29,024.00. Following this transaction, Kihara James now holds 29,129 shares of ACAD.

This sale represents a 4.00% decrease in Kihara James's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, May 4, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 5, 2026, 1 day after the trade was made.

Acadia Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.